January 28, 2022 PAO-01-22-R250-11
At this stop on Pharma's Almanac's Road to 50 States trip, Mark Gagnon, Vice President of Construction for Genesis AEC, talks to Nigel about the emergence of 3D bioprinting, as well as the advantages and disadvantages of modular and stick-built constructions.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Genesis AEC is an award-winning consulting, architecture, engineering, and construction management firm. Built on quality and trusted relationships, they partner with life science organizations to conceive, build, and maintain compliant, efficient, and inspiring facilities. Bringing more than 25 years of experience, they complement the scientific expertise of their clients as they usher in the next generation of life-saving therapies, treatments, and technologies. With clients ranging from emerging start-ups to global leaders, they deliver successful projects across all facets of the drug development process from R+D labs to commercialization. Whether it’s providing AE support for existing sites; commissioning, validation, and qualification (CQV) for specific processes or equipment; or turnkey design-build solutions, the Genesis AEC team blends sound science and technical expertise with quality assurance and safety measures to deliver unparalleled results.